<i>In Vitro</i> and <i>Ex Vivo</i> Characterisation of Capsaicin-loaded Liposomal Film for Transdermal Delivery

Background: Capsaicin has anti-inflammatory and analgesic effects. It undergoes extensive first-pass metabolism and is limited to clinical use due to its pungency. Aim: To overcome the associated drawbacks, the study aimed to develop a CAP-liposomal film for dermal delivery. Methods: The CAP-liposomes were developed by the ethanol injection technique and evaluated for particle size distribution, zeta potential, % Entrapment Efficiency (EE) and in vitro drug release studies, respectively. The films were developed using sodium carboxymethylcellulose as a film base by the solvent casting method and evaluated for particle size distribution, zeta potential, folding endurance, % drug content, in vitro drug release, and ex vivo permeation studies, respectively. Results: CAP-liposomes were optimised based on the results of particle size distribution, zeta potential, % EE, and in vitro drug release, which were found to be in the ranges of 234 to 380 nm, -24.1 to -41.4 mV, 40.67 to 76.52%, and 61 to 94%, respectively. For in vitro drug release of CAP-lipofilm and SALONPAS ® , it showed 87.6% at 12h and 82.9% at 6 h, whereas for ex vivo permeation studies, it showed 75.8% at 12h and 71.6% at 6h, respectively. Conclusion: The CAP-lipofilm showed superior results as compared to other test films in all characterisation parameters. Based on the key findings of the current study, the lipofilm showed prolonged permeation of CAP rather than SALONPAS ® . Therefore, CAP-lipofilm was thought to offer maximum penetration and controlled release for anti-inflammatory treatment. Major Findings: The CAP-lipofilm was successfully designed with an adopted formulation composition, and it showed better results than SALONPAS®. These findings may be helpful for in vivo activity in future research.

View article page

Download PDF